Centene Corporation
Centene to Discuss Financial Outlook at UBS 2025 Global Healthcare Conference
Summary
Centene Corporation announced its participation in the UBS 2025 Global Healthcare Conference on November 11, 2025. During the conference, management will discuss the Company's financial outlook, reiterating its full-year 2025 GAAP forecast of a diluted loss per share not exceeding $(12.85) and an adjusted diluted EPS forecast of at least $2.00. A live audio webcast of the conference presentation will be accessible via the Company's website.
Profitelligence Alerts
Get alerts for CNC
Be first to know when Centene Corporation files with the SEC.
Filing Categories
Advertisement
About Centene Corporation
Centene Corporation is a diversified healthcare enterprise providing a comprehensive range of managed care services to government-sponsored healthcare programs. Specializing in serving uninsured and underinsured populations, Centene offers health plans, benefits management, and other related services. It operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Medicaid, Medicare Advantage, and the Health Insurance Marketplace, impacting millions of lives across the United States. Meanwhile, the Specialty Services segment enhances healthcare quality and affordability through offerings such as pharmacy solutions, behavioral health, and optometry services. Founded in 1984 and headquartered in St. Louis, Missouri, Centene plays a significant role in the healthcare sector by addressing accessibility and cost challenges, thereby shaping market trends and influencing policy developments. As a major participant in the managed care industry, Centene is crucial for promoting coordinated care and improving health outcomes for vulnerable populations.
Official SEC Documents
Advertisement